Updates are available Correction dated 2024-07-15
Click to view Correction: https://doi.org/10.1038/s41591-024-03174-5
-
Authors
Kinget, Lisa https://orcid.org/0000-0002-7479-4793
Naulaerts, Stefan
Govaerts, Jannes
Vanmeerbeek, Isaure
Sprooten, Jenny
Laureano, Raquel S.
Dubroja, Nikolina
Shankar, Gautam
Bosisio, Francesca M. https://orcid.org/0000-0002-8874-2003
Roussel, Eduard
Verbiest, Annelies
Finotello, Francesca https://orcid.org/0000-0003-0712-4658
Ausserhofer, Markus
Lambrechts, Diether https://orcid.org/0000-0002-3429-302X
Boeckx, Bram
Wozniak, Agnieszka
Boon, Louis
Kerkhofs, Johan
Zucman-Rossi, Jessica https://orcid.org/0000-0002-5687-0334
Albersen, Maarten
Baldewijns, Marcella
Beuselinck, Benoit https://orcid.org/0000-0001-7427-9102
Garg, Abhishek D. https://orcid.org/0000-0002-9976-9922
- License Information
-
More Information
Article History
Received: 1 September 2023
Accepted: 5 April 2024
First Online: 21 May 2024
Change Date: 15 July 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41591-024-03174-5
Competing interests
: B. Beuselinck: speaker’s bureau: BMS, Pfizer, MSD, Ipsen; unrestricted research grants: BMS; advisory board: BMS, MSD, Ipsen. A.D.G. received consulting/advisory/lecture honoraria from Boehringer Ingelheim (Germany), Miltenyi Biotec (Germany), Novigenix (Switzerland), SOTIO (Czech Republic) and IsoPlexis (United States) and received R&D project funding from SOTIO. F.F. consults for iOnctura. The other authors declare no competing interests.
